Drug Profile
Research programme: inflammation therapy - Pfizer
Alternative Names: 19GJ; Inflammation therapy research programme - PfizerLatest Information Update: 16 Mar 2022
Price :
$50
*
At a glance
- Originator Arena Pharmaceuticals
- Class Small molecules
- Mechanism of Action G protein-coupled receptor antagonists; G protein-coupled receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Suspended Asthma; Inflammation; Inflammatory bowel diseases; Rheumatoid arthritis
Most Recent Events
- 11 Mar 2022 Arena Pharmaceuticals has been acquired and merged into Pfizer
- 02 Aug 2005 This programme is still in active development - (BIO-2005)
- 23 Mar 2003 Preclinical trials in Asthma in USA (unspecified route)